Actively Recruiting
Study of Hepatitis B Virus Impact on Inflammatory Bowel Disease in Egyptian Adults
Led by Tanta University · Updated on 2025-03-18
162
Participants Needed
1
Research Sites
1 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating how hepatitis B virus HBV infection affects the clinical course and outcomes of inflammatory bowel disease IBD in Egyptian patients. The study compares the extent, location, severity, and behavior of IBD between patients with and without HBV infection to better understand the relationship between these conditions. Participants include two groups 81 IBD patients with HBV infection and 81 IBD patients without HBV infection. Researchers collect detailed histories including hospital admissions, disease flares, surgeries, medications, and follow-up duration. They also gather data from clinical examinations, laboratory tests, abdominal ultrasound, and endoscopic examinations. During the study, participants undergo assessments such as the Truelove-Witts severity index, and researchers monitor hospital admission rates, surgical treatments, disease flare rates, and mortality over an average of six months. This observational study involves no intervention but thorough data review to assess the impact of HBV on IBD outcomes.
CONDITIONS
Brief Title
Impact of Hepatitis B Virus on Inflammatory Bowel Disease
Research Team
R
Rania M Elkafoury, MD
N
Nabila A Elgazzar, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
